Envestnet Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$404K	Sell	42,422 -11,643	-22%	-$90.4K	﹤0.01%	4080
2025 Q4	$422K	Buy	54,065 +24,352	+82%	+$176K	﹤0.01%	3822
2025 Q3	$226K	Buy	29,713 +19,312	+186%	+$161K	﹤0.01%	4259
2025 Q2	$93.2K	Buy	10,401 +119	+1%	+$1.11K	﹤0.01%	4344
2025 Q1	$77.1K	Buy	+10,282	New	+$82.9K	﹤0.01%	4265
2024 Q3	–	Sell	-10,335	Closed	-$63.9K	–	4228
2024 Q2	$63.9K	Sell	10,335 -7,460	-42%	-$41.2K	﹤0.01%	4090
2024 Q1	$90.4K	Buy	+17,795	New	+$100K	﹤0.01%	4071
2018 Q3	–	Sell	-119	Closed	-$1K	–	1369
2018 Q2	$1K	Hold	119	–	–	﹤0.01%	2786
2018 Q1	$1K	Hold	119	–	–	﹤0.01%	2759
2017 Q4	$1K	Hold	119	–	–	﹤0.01%	2895
2017 Q3	$1K	Hold	119	–	–	﹤0.01%	2841
2017 Q2	$1K	Hold	119	–	–	﹤0.01%	2982
2017 Q1	$1K	Hold	119	–	–	﹤0.01%	3042
2016 Q4	$1K	Buy	+119	New	+$619	﹤0.01%	3020